PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells

Wenqiang Huang; Weiwei Guo; Xue You; Yi Pan; Zhenyang Dong; Gaozhen Jia; Chenghua Yang; Yan Chen

doi:10.18632/oncotarget.9807

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells

Wenqiang Huang, Weiwei Guo, Xue You, Yi Pan, Zhenyang Dong, Gaozhen Jia, Chenghua Yang and Yan Chen _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:53948-53958. https://doi.org/10.18632/oncotarget.9807

Metrics: PDF 2261 views | HTML 2537 views | ?

Abstract

Wenqiang Huang1,*, Weiwei Guo1,*, Xue You1,2, Yi Pan1, Zhenyang Dong3, Gaozhen Jia3, Chenghua Yang1,4, Yan Chen1,2

1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200031, China

2School of Life Sciences and Technology, Shanghai Tech University, Shanghai, 200031, China

3Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China

4Joint Center for Translational Research of Chronic Diseases, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 2000433, China

*These authors contributed equally to this work

Correspondence to:

Yan Chen, email: [email protected]

Chenghua Yang, email: [email protected]

Keywords: human prostate cancer, PAQR3, cell proliferation, cell migration, tumor xenograft

Received: February 20, 2016 Accepted: May 28, 2016 Published: June 03, 2016

ABSTRACT

As a newly discovered tumor suppressor, the potential function of PAQR3 in human prostate cancer has not been demonstrated. In this study, we report that PAQR3 is able to inhibit the growth and migration of human prostate cancer cells both in vitro and in vivo. Overexpression of PAQR3 inhibits the proliferation of PC3 and DU145 cells by both MTT and colony formation assays. Consistently, knockdown of PAQR3 enhances the proliferation of these cells. In wound-healing and transwell assays, overexpression of PAQR3 reduces the migration of PC3 and DU145 cells, while PAQR3 knockdown increases it. In a tumor xenograft model, overexpression of PAQR3 suppresses tumor growth of PC3 cells in vivo, while PAQR3 knockdown promotes the tumor growth. PAQR3 is also able to inhibit serum-induced phosphorylation of AKT and ERK in both PC3 and DU145 cells. In addition, PAQR3 suppresses the expression of epithelial-mesenchymal transition (EMT) markers in PC3 cells. Collectively, these data indicate that PAQR3 has a tumor suppressive activity in human prostate cancer cells and may stand out as a potential therapeutic target for prostate cancers.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9807

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells

Abstract